Friday, December 5, 2008

Cancer Research Giants Collaborate To Present The CTRC-AACR San Antonio Breast Cancer Symposium

Cancer Research Giants Collaborate To Present The CTRC-AACR San Antonio Breast Cancer Symposium
This year marks the first San Antonio Breast Cancer Symposium to include the collaborative efforts of the American Association for Cancer Research, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and the Baylor College of Medicine.

More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current And Pipeline Therapies
More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.

Gene Packaging Tells Story Of Cancer Development
To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging. Specifically, their findings in the December 2, 2008, issue of PLoS Biology point to the three dimensional chromatin packaging around genes formed by tight, rosette-like loops of Polycomb group proteins (PcG).

Geron Announces Initiation Of Phase I Clinical Trial Of Vaccine Candidate Targeting Telomerase By Merck & Co., Inc.
Geron Corporation (Nasdaq:GERN) announced today that its collaborator, Merck & Co., Inc., has initiated a Phase I clinical trial of V934/V935, a non-dendritic cell based cancer vaccine candidate targeting telomerase. The trial will assess the safety, tolerability and immunogenicity of the vaccine candidate in patients with solid tumors, including non-small cell lung cancer and prostate carcinoma.

VentiRx Pharmaceuticals Commences Phase I Clinical Trial Of VTX-2337, A Novel TLR8 Agonist For The Treatment Of Oncology
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today that it has initiated a Phase I clinical trial of VTX-2337, a selective TLR8 agonist for the treatment of cancer. The multi-center clinical trial is being conducted at the Mayo Clinic Arizona and TGen Drug Development Services (TD2) both in Scottsdale, Arizona.

Acid Reflux Symptoms and Signs

Acid reflux is a condition that can be quite frustrating and irritating because it produces a burning sensation and at the wrong time, that is just when you are about to start enjoying your good night's sleep. It would therefore be of help to you if you got an idea of what the acid reflux symptoms are like so that you are able to take precautions well in advance before you are rudely jolted out of bed to look for antacids. Among the most common characteristics of this condition is frequency of heartburn.

Late-Onset Hypogonadism: New Recommendations By Scientific Societies

Late-Onset Hypogonadism: New Recommendations By Scientific Societies
The January issue of European Urology, the official journal of the European Association of Urology published by Elsevier, will feature new recommendations on late-onset hypogonadism (LOH), recently formulated by major scientific organizations. LOH is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms and a deficiency in serum testosterone levels.